STABILITY OF DILUTED AND RECONSTITUTED ANTINEOPLASTIC DRUGS: UPDATED 2014
PP-006
MICROWAVE FREEZE-THAW TREATMENT OF INJECTABLE DRUGS: A REVIEW OF THE LITERATURE FROM 1980 TO 2014
PP-005
COMPLETE FORMULAE FOR PARENTERAL NUTRITION IN NEONATAL INTENSIVE CARE: A STABILITY TRIAL
PP-004
QUALITY CONTROL ASSESSMENT OF CYTOTOXIC BAGS BY UV-RAMAN SPECTROMETRY
PP-003
PRODUCTION AND STABILITY OF A READY-TO-USE HYDROXOCOBALAMIN SOLUTION FOR PAEDIATRIC PARENTERAL USE
PP-001
Validation of cleaning in a multipurpose facility for non-sterile products
PP-033
PHYSICO-CHEMICAL STABILITY OF CABAZITAXEL - CONTAINING PREMIX SOLUTION AND READY-TO-ADMINISTER SOLUTIONS
PP-032
DESIGN OF TOCILIZUMAB DESENSITISATION PROTOCOL AFTER A HYPERSENSITIVITY REACTION
PP-022
EXTENDED STABILITY OF 2.5 MG/ML BORTEZOMIB SOLUTION IN SYRINGES AND OPENED VIALS
PP-021
VALIDATION AND IMPLEMENTATION OF AN ANALYTICAL QUALITY CONTROL METHOD IN PRETERM PARENTERAL NUTRITION
PP-018
ADVANCE PREPARATION OF CHEMOTHERAPY – CONSEQUENCES
PP-016
CENTRALISED PREPARATION OF METHOTREXATE SYRINGES: A COST CONTROL OPTION BETWEEN PRIMARY CARE PHARMACY AND HOSPITAL PHARMACY
PP-011
IMPLEMENTATION OF A PROCESS OPTIMISATION PROTOCOL FOR THE PREPARATION OF READY-TO-USE (RTU) INTRACAMERAL CEFUROXIME FOR ENDOPHTHALMITIS PROPHYLAXIS (EP) AFTER CATARACT SURGERY
PP-009
IMPLEMENTING APPROPRIATE COMPOUNDED PAEDIATRIC CHLORAL HYDRATE RECTAL DOSAGE FORM
PP-008
IMPLEMENTING APPROPRIATE COMPOUNDED PAEDIATRIC MIDAZOLAM 3MG/ML SYRUP IN THE CLINICAL HOSPITAL BITOLA
